Structure Based Design of CYP51 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|1|30-39

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.1, 2017-01, pp. : 30-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 337-344

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum

By Yuan Yongze   Han Rui   Cao Qianwen   Yu Jinhui   Mao Jiali   Zhang Tingfu   Wang Shengqiang   Niu Yuhui   Liu Deli  

Marine Drugs, Vol. 15, Iss. 4, 2017-04 ,pp. : 107-107

MDPI

Access to resources Recommend Favorite

Design of Peptidomimetic Based DPP-IV Inhibitors, Devoid of CYP Liabilities

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 9, 2012-11 ,pp. : 867-873

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 315-326

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Structure-Based Design of EGFR Inhibitors

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 817-829

Bentham Science Publishers

Access to resources Recommend Favorite